[ASPECTS AND PREVENTION OF MAJOR COMPLICATIONS OF PROLONGED CORTISONOTHERAPY OF ASTHMA WITH CONTINUOUS DYSPNEA].
D000305:Adrenal Cortex Hormones; D000309:Adrenal Insufficiency; D000324:Adrenocorticotropic Hormone / Q000633:toxicity*; D001249:Asthma; D001847:Bone Diseases; D002128:Calcium Metabolism Disorders; D004417:Dyspnea; D006471:Gastrointestinal Hemorrhage; D006396:Hematemesis; D010437:Peptic Ulcer; D010760:Phosphorus Metabolism Disorders; D013959:Thyroid Diseases; D014116:Toxicology
D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone
ADRENAL CORTEX HORMONES; ADRENAL GLAND HYPOFUNCTION; ASTHMA; BONE DISEASES; CALCIUM METABOLISM DISORDERS; CORTICOTROPIN TOXICOLOGY; HEMATEMESIS; HEMORRHAGE, GASTROINTESTINAL; PEPTIC ULCER; PHOSPHORUS METABOLISM DISORDERS; THYROID DISEASES; TOXICOLOGIC REPORT
ASPECTS ET PROPHYLAXIE DES COMPLICATIONS MAJEURES DE LA CORTISONOTH'ERAPIE AU LONG COURS DE L'ASTHME 'A DYSPN'EE CONTINUE.